Ask about this productRelated genes to: TRAILR1 antibody
- Gene:
- TNFRSF10A NIH gene
- Name:
- TNF receptor superfamily member 10a
- Previous symbol:
- -
- Synonyms:
- DR4, Apo2, TRAILR-1, CD261, TRAILR1
- Chromosome:
- 8p21.3
- Locus Type:
- gene with protein product
- Date approved:
- 1998-12-04
- Date modifiied:
- 2018-01-25
Related products to: TRAILR1 antibody
Related articles to: TRAILR1 antibody
- Rheumatoid arthritis (RA) is a chronic inflammatory disease of immune-mediated origin. Janus kinase inhibitors (JAK inhibitors) have expanded therapeutic options in recent years; however, clinical response varies among patients, and no biomarkers are currently available to predict their efficacy. The aim of this study was to analyze the association between pharmacogenetic variants and clinical response to JAK inhibitors in patients with RA. - Source: PubMed
Publication date: 2026/04/23
Plasencia-Rodríguez ChamaidaNovella-Navarro MartaValdivieso Shephard Juan LuisMartínez-Feito AnaReche-Yebra KerenJuárez-García ManuelVillalba-Yllán AlejandroRubio-Lepe Tania SArias PedroCollada Sánchez Victoria LuciaMartin-López SusanaLosantos-García ItsasoBorobia Alberto MRosas-Alonso Rocío - Exercise is known to exert systemic effects associated with improved cardiovascular fitness and epigenetic modifications. However, the relationships between systemic epigenetic markers and physical fitness indicators remain insufficiently characterized. - Source: PubMed
Publication date: 2026/04/15
Torma FerencSantos EmersonJókai MátyásBábszky ZsófiaBábszky GergelyMozaffaritabar SorooshHerai Roberto HPinho Ricardo AHiguchi MitsuruGu YaodongRadák Zsolt - Accurate biomarkers that reflect disease activity, severity, and molecular pathophysiology in multiple sclerosis (MS) remain an unmet diagnostic need. We compared the performance of the established biomarkers, neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP), with emerging candidates in CSF and serum. - Source: PubMed
Publication date: 2026/04/23
Oechtering JohannaSchaedelin Sabine AnnaMaleska Maceski AleksandraStein KerstinGenc NafiyeEinsiedler MaximilianBenkert PascalWillemse ElineDerfuss Tobias JFischer-Barnicol BettinaD'Souza MarcusRegeniter AxelHu WayneQureshi FerhanFinkener SebastianMueller StefanieHoepner RobertLalive Patrice HPot CarolineGobbi ClaudioZecca ChiaraRoth PatrickWiendl HeinzLünemann Jan DKappos LudwigGranziera CristinaLeppert DavidKuhle Jens - To investigate the role of ( in chronic central serous chorioretinopathy (cCSCR), polypoidal choroidal vasculopathy (PCV), and neovascular age-related macular degeneration (nAMD). - Source: PubMed
Publication date: 2026/03/17
Chen Zhen JiYu JunNg Danny S CHo MaryZhu XintianBrelen Marten EYoung Alvin LYam Jason CTham Clement CPang Chi PuiChen Li Jia - Allergic rhinitis (AR) affects 10-25% of the global population, with nasal epithelial cell (NEC) dysfunction acting as a central driver of its pathogenesis. Allergen-specific immunotherapy (AIT) is the sole disease-modifying treatment for AR; however, its optimization is hindered by the lack of validated predictive biomarkers. N6-methyladenosine (m6A) is a pivotal epitranscriptomic regulator of immune and epithelial homeostasis. This study aims to delineate the m6A modification landscape in NECs during AIT to identify candidate genes associated with clinical efficacy and elucidate the underlying molecular mechanisms. - Source: PubMed
Publication date: 2026/04/19
Lai ShiminYu LeiSun LinZheng HongyuanLu TongLi ZhengqiChen ChanghuiWei YiWen Weiping